Skip to main content
. 2014 Apr;55(4):765–772. doi: 10.1194/jlr.D045963

TABLE 4.

Candidate mutation detection rates within experimental dyslipidemia cohorts

Candidate Mutation
Disease Positive Negative
FH (%) (n = 19) 8 (42.1) 11 (57.9)
HTG (%) (n = 14) 12 (85.7) 2 (14.3)
MODY (%) (n = 2) 1 (50) 1 (50)
FPLD (%) (n = 2) 0 (0) 2 (100)
HBL (%) (n = 1) 1 (100) 0 (0)
Totala (%) (n = 38) 22 (57.9) 16 (42.1)
a

FH patients previously screened for candidate mutations (n = 10) are not included here.